A detailed history of Kings Path Partners LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Kings Path Partners LLC holds 1,185 shares of JNJ stock, worth $196,520. This represents 0.1% of its overall portfolio holdings.

Number of Shares
1,185
Previous 8,528 86.1%
Holding current value
$196,520
Previous $1.23 Billion 84.07%
% of portfolio
0.1%
Previous 0.53%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

Apr 04, 2025

SELL
$142.06 - $167.7 $1.04 Million - $1.23 Million
-7,343 Reduced 86.1%
1,185 $197 Million
Q2 2024

Jul 30, 2024

BUY
$144.38 - $157.78 $1.23 Million - $1.35 Million
8,528 New
8,528 $1.25 Billion

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $434B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Kings Path Partners LLC Portfolio

Follow Kings Path Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kings Path Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kings Path Partners LLC with notifications on news.